Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/14/2023
CDE Issues the Technical Guidelines for Clinical Research of New Compo...
4/14/2023
Drug R&D and Product Registration News Digest April 2023 (2)
4/14/2023
Recent Executive Moves
4/13/2023
Chinese VMS OTC Market Growth Slows to 5.3% in 2022 amid Covid-related...
4/13/2023
Pfizer Collaborates with Sinopharm to Expand in China
4/13/2023
China to Establish A Vaccine Development Center with Brazil
4/12/2023
Specialised Therapeutics Partners with CTTQ-Akeso to Commercialise Ne...
4/12/2023
China Issues Action Plan to Combat Endemic Diseases
4/12/2023
CDE Issues the Technical Guidelines for Clinical Trials of Respiratory...
4/12/2023
CDE Issues the Technical Guidelines of Quantitative Methodologies for ...
4/12/2023
CDE Issues the List of External Clinical Evaluation Experts of Pediatr...
4/12/2023
Bain: China Drags Regional Healthcare PE
4/12/2023
Yicai: Most Chinese Regions Eye Healthcare Industry Upgrades
4/12/2023
Outlook of China's Health Systems (Informa)
4/12/2023
Trailing AstraZeneca and Merck, Junshi Reports Phase 3 Ovarian Cancer ...
4/11/2023
Seizing On Asia's Opportune Market for Novel Vaccines (PharmExec/Simo...
4/11/2023
A Brief Review of China Pharmaceutical Anti-Monopoly in the Year of 20...
4/11/2023
NMPA Solicits Public Comments on the Drug Regulatory Informatization S...
4/10/2023
FT: Astellas to Stay Put in China Despite Growing Geopolitical Tension
4/8/2023
CDE Issues the Technical Guidelines for Clinical Research of Antitumor...
4/8/2023
CDE Issues on the Technical Guidelines for Drug Research Based on Anim...
4/8/2023
South Korean Biotech Companies Seek to Diversify from China as US Tens...
4/8/2023
Recent Executive Moves
4/8/2023
Drug R&D and Registration News Digest April 2023 (1)
4/8/2023
EU-China Relations – Trade, Investment, and Recent Developments (Chin...
4/8/2023
Investing in China's Greater Bay Area: Tapping into Long-Term Opportun...
4/6/2023
A Recently Terminated In-Licensing Deal Highlights Why Regulatory Diff...
4/5/2023
China's Out-Licensing Boom Continued in February with Big Oncology Dru...
4/5/2023
WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Conti...
4/5/2023
Pharmaron Plans UK Gene Therapy Expansion
Page:
50
/
719
Total number of articles:
21546
:
[First]
[<<]
[48]
[49]
[50]
[51]
[52]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit